StonvexLoading…
StonvexStonvexStonvexCore line items from LRCX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-06-29 | Annual 2024 2024-06-30 | Annual 2023 2023-06-25 | Annual 2022 2022-06-26 |
|---|---|---|---|---|
Revenue | $18.44B | $14.91B | $17.43B | $17.23B |
Operating Income | $5.90B | $4.26B | $5.17B | $5.38B |
Net Income | $5.36B | $3.83B | $4.51B | $4.61B |
EPS (Diluted) | $4.15 | $2.90 | $3.32 | $32.75 |
Total Assets | $21.35B | $18.74B | $18.78B | $17.20B |
Total Liabilities | $11.48B | $10.21B | $10.57B | $10.92B |
Cash & Equivalents | $6.39B | $5.85B | $5.34B | $3.52B |
Free Cash Flow OCF − CapEx | $5.41B | $4.26B | $4.68B | $2.55B |
Shares Outstanding | 1.27B | 1.30B | 133.30M | 136.97M |